Your browser doesn't support javascript.
loading
Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study.
Raverdy, Violeta; Cohen, Ricardo V; Caiazzo, Robert; Verkindt, Helene; Petry, Tarissa Beatrice Zanata; Marciniak, Camille; Legendre, Benjamin; Bauvin, Pierre; Chatelain, Estelle; Duhamel, Alain; Drumez, Elodie; Oukhouya-Daoud, Naima; Chetboun, Mikael; Baud, Gregory; Ahlqvist, Emma; Wierup, Niels; Asplund, Olof; Laferrère, Blandine; Groop, Leif; Pattou, FranÇois.
Afiliação
  • Raverdy V; University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, UMR 1190 Translational Research for Diabetes, European Genomic Institute for Diabetes, Lille, France.
  • Cohen RV; The Center for the Treatment of Obesity and Diabetes, Oswaldo Cruz German Hospital, São Paulo, Brazil.
  • Caiazzo R; University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, UMR 1190 Translational Research for Diabetes, European Genomic Institute for Diabetes, Lille, France; CHU Lille, Integrated Center for Obesity, General and Endocrine Surgery, Lille, France.
  • Verkindt H; University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, UMR 1190 Translational Research for Diabetes, European Genomic Institute for Diabetes, Lille, France; CHU Lille, Integrated Center for Obesity, General and Endocrine Surgery, Lille, France.
  • Petry TBZ; The Center for the Treatment of Obesity and Diabetes, Oswaldo Cruz German Hospital, São Paulo, Brazil.
  • Marciniak C; University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, UMR 1190 Translational Research for Diabetes, European Genomic Institute for Diabetes, Lille, France; CHU Lille, Integrated Center for Obesity, General and Endocrine Surgery, Lille, France.
  • Legendre B; University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, UMR 1190 Translational Research for Diabetes, European Genomic Institute for Diabetes, Lille, France.
  • Bauvin P; University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, UMR 1190 Translational Research for Diabetes, European Genomic Institute for Diabetes, Lille, France.
  • Chatelain E; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UMS 2014-PLBS, Bilille, Lille, France.
  • Duhamel A; CHU Lille, University Lille, ULR 2694-METRICS: Évaluation des technologies de santé et des pratiques médicales, Lille, France.
  • Drumez E; CHU Lille, University Lille, ULR 2694-METRICS: Évaluation des technologies de santé et des pratiques médicales, Lille, France.
  • Oukhouya-Daoud N; University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, UMR 1190 Translational Research for Diabetes, European Genomic Institute for Diabetes, Lille, France; CHU Lille, Integrated Center for Obesity, General and Endocrine Surgery, Lille, France.
  • Chetboun M; University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, UMR 1190 Translational Research for Diabetes, European Genomic Institute for Diabetes, Lille, France; CHU Lille, Integrated Center for Obesity, General and Endocrine Surgery, Lille, France.
  • Baud G; University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, UMR 1190 Translational Research for Diabetes, European Genomic Institute for Diabetes, Lille, France; CHU Lille, Integrated Center for Obesity, General and Endocrine Surgery, Lille, France.
  • Ahlqvist E; Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Wierup N; Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Asplund O; Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Laferrère B; Diabetes Research Center, Division of Endocrinology, Department of Medicine, Columbia University, New York City, NY, USA.
  • Groop L; Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden; Institute for Molecular Medicine Finland, Helsinki University, Helsinki, Finland.
  • Pattou F; University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, UMR 1190 Translational Research for Diabetes, European Genomic Institute for Diabetes, Lille, France; CHU Lille, Integrated Center for Obesity, General and Endocrine Surgery, Lille, France. Electronic address: francois.pattou@univ-lille
Lancet Diabetes Endocrinol ; 10(3): 167-176, 2022 03.
Article em En | MEDLINE | ID: mdl-35148818
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Resistência à Insulina / Derivação Gástrica / Diabetes Mellitus Tipo 2 / Cirurgia Bariátrica Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Resistência à Insulina / Derivação Gástrica / Diabetes Mellitus Tipo 2 / Cirurgia Bariátrica Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido